Pancreatic Cancer

Our highly experienced and knowledgable team of dedicated doctors combine innovative therapies, precision treatment, and evidence-based medicine to provide world-class care to people with pancreatic cancer. Our specialists are at the forefront of groundbreaking research, studying promising new treatments and pioneering methods for detecting pancreatic cancer earlier, when it’s most treatable.

Our experts create an individualized treatment plan for you, drawing on our expertise in endoscopic and surgical treatments as well as medical therapies. Learn more about our comprehensive care for pancreatic cancer at Perlmutter Cancer Center’s Pancreatic Cancer Center.

Clinical Trials and Research Studies

Phase 1

A Phase 1 bioequivalence study between the current commercial formulation & the proposed soft gel capsule formulation of talazoparib & food effect study for the proposed talazoparib soft gel capsule formulation in participants w/ advanced solid tumors

Learn More

Phase 5

A Phase I/II Study of M3814 and Avelumab in Combination with Hypofractionated Radiation in Patients with Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies

Learn More

Phase 1

A Phase 1 First-in Human Multi-Center Open Label Dose-Escalation Study to Determine the Safety Tolerability Pharmacokinetics and RP2D of ABBV-151 as a Single Agent and in Combination with ABBV-181 in Subjects with Locally Advanced or Metastatic Solid Tumors (AbbVie M19-345)

Learn More

Phase 5

A Phase I study of Anetumab Ravtansine in Combination with either Anti-PD-1 Antibody or Anti-CTLA4 and Anti-PD-1 Antibodies or Anti-PD-1 Antibody and Gemcitabine in Mesothelin-Positive Advanced Pancreatic Adenocarcinoma

Learn More